These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9760107)

  • 1. NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test.
    Kask A; Rägo L; Harro J
    Neuroreport; 1998 Aug; 9(12):2713-6. PubMed ID: 9760107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
    Kask A; Rägo L; Harro J
    Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPY-Y
    Vázquez-León P; Ramírez-San Juan E; Marichal-Cancino BA; Campos-Rodríguez C; Chávez-Reyes J; Miranda-Páez A
    Pharmacol Biochem Behav; 2020 Dec; 199():173071. PubMed ID: 33171140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
    Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
    Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
    Kask A; Rägo L; Harro J
    Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats.
    Kask A; Kivastik T; Rägo L; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 May; 23(4):705-11. PubMed ID: 10390728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat.
    Raposinho PD; Broqua P; Hayward A; Akinsanya K; Galyean R; Schteingart C; Junien J; Aubert ML
    Neuroendocrinology; 2000 Jan; 71(1):2-7. PubMed ID: 10644893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
    De Araújo JE; Huston JP; Brandão ML
    Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.
    Sajdyk TJ; Schober DA; Gehlert DR
    Neuropharmacology; 2002 Dec; 43(7):1165-72. PubMed ID: 12504923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats.
    Schmitt ML; Coelho W; Lopes-de-Souza AS; Guimarães FS; Carobrez AP
    Neurosci Lett; 1995 Apr; 189(2):93-6. PubMed ID: 7609926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
    Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
    Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat.
    Yang SN; Finnman UB; Fuxe K
    Neuroreport; 1996 Nov; 7(15-17):2701-5. PubMed ID: 8981451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y Y1-receptor stimulation is required for physiological amplification of preovulatory luteinizing hormone surges.
    Leupen SM; Besecke LM; Levine JE
    Endocrinology; 1997 Jul; 138(7):2735-9. PubMed ID: 9202211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors.
    Gariboldi M; Conti M; Cavaleri D; Samanin R; Vezzani A
    Eur J Neurosci; 1998 Feb; 10(2):757-9. PubMed ID: 9749738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine.
    Zanoveli JM; Pobbe RL; de Bortoli VC; Carvalho MC; Brandão ML; Zangrossi H
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1079-88. PubMed ID: 19941697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.
    Kask A; Rägo L; Harro J
    Eur J Pharmacol; 1996 Dec; 317(2-3):R3-4. PubMed ID: 8997632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.